PHIBROMONENSIN 100 MONENSIN FEED ADDITIVE PREMIX

Country: Australia

Language: English

Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Buy It Now

Patient Information leaflet (PIL)

20-12-2004

Summary of Product characteristics (SPC)

01-07-2013

Active ingredient:

MONENSIN AS MONENSIN SODIUM

Available from:

PHIBRO ANIMAL HEALTH PTY LIMITED

INN (International Name):

monensin as sodium(100g/kg)

Pharmaceutical form:

ORAL POWDER, PRE-MIX

Composition:

MONENSIN AS MONENSIN SODIUM ANTIPROTOZOAL Active 100.0 g/kg

Units in package:

25kg

Class:

VM - Veterinary Medicine

Manufactured by:

PHIBRO ANIMAL HEALTH

Therapeutic group:

Therapeutic area:

NUTRITION & METABOLISM

Therapeutic indications:

Product summary:

Poison schedule: 6; Withholding period: WHP: Cattle: Meat: Nil Milk: Nil Goa ts: Meat: Nil Milk: DO NOT USE PhibroM onensin in goats producing milk for hum an consumption. Poultry: Meat: Nil Eg gs: DO NOT USE in birds producing eggs for human consumption.; Host/pest details: CATTLE: [BLOAT, COCCIDIOSIS, IMPROVE FEED EFFICIENCY, IMPROVE REPRODUCTIVE PERFORMANCE]; CATTLE - FEEDLOT: [BLOAT, IMPROVE FEED EFFICIENCY, PRODUCTIVITY IMPROVEMENTS]; DAIRY CATTLE: [BLOAT, COCCIDIOSIS, IMPROVEMENT OF MILK PRODUCTION, PRODUCTIVITY IMPROVEMENTS]; GOAT: [COCCIDIOSIS]; POULTRY: [COCCIDIOSIS]; Poison schedule: 6; Withholding period: ; Host/pest details: CATTLE: [BLOAT, COCCIDIOSIS, IMPROVE FEED EFFICIENCY, IMPROVE REPRODUCTIVE PERFORMANCE]; CATTLE - FEEDLOT: [BLOAT, IMPROVE FEED EFFICIENCY, PRODUCTIVITY IMPROVEMENTS]; DAIRY CATTLE: [BLOAT, COCCIDIOSIS, IMPROVEMENT OF MILK PRODUCTION, PRODUCTIVITY IMPROVEMENTS]; GOAT: [COCCIDIOSIS]; POULTRY: [COCCIDIOSIS]; Cattle: feed efficiency, bloat control (feedlot); dairy cows: bloat control, milk production, non-clinical ketosis (reduction); heifers: weight gain, feed efficiency, reproductive performance; cattle, chickens and goats: prevention of coccidiosis.DO NOT USE in goats producing milk for human consumption. DO NOT USE in chickens producing eggs for human consumption

Authorization status:

Registered

Authorization date:

2023-07-01

Patient Information leaflet

_MONENSIN FEED ADDITIVE PREMIX_
To improve feed efficiency in feedlot cattle. To aid in the control of
bloat in feedlot cattle and dairy cows. To increase milk production in
dairy cows under many conditions. To improve weight gain, feed
efficiency and reproductive performance in heifers. To improve weight
gain and feed efficiency in pasture cattle. To aid in reducing the
severity of nonclinical ketosis in lactating dairy cows. To aid in the
prevention of coccidiosis in chickens _(Eimeria acervulina, E.
brunetti, _
_E. maxima, E. mivati, E. necatrix, E. tenella),_ cattle _(E. zuernii,
E. bovis)_
and goats _(E. arloingi, E. christenseni, E. ninakohlyakimovae)._
_MONENSIN (AS MONENSIN SODIUM) 100G/KG_
Unit 4, 129 Magowar Road,
Girraween, New South Wales,
Australia 2145
*Phibro Animal Health Trademark
POISON
KEEP OUT OF REACH OF CHILDREN
READ SAFETY DIRECTIONS BEFORE OPENING OR USING
FOR ANIMAL TREATMENT ONLY
DIRECTIONS FOR USE
RESTRAINTS
DO NOT USE PHIBROMONENSIN IN GOATS PRODUCING MILK FOR HUMAN
CONSUMPTION.
DO NOT USE IN CHICKENS PRODUCING EGGS FOR HUMAN CONSUMPTION.
CONTRAINDICATIONS
DOGS, HORSES OR OTHER EQUINES MUST NOT BE ALLOWED ACCESS TO FEEDS
CONTAINING PHIBROMONENSIN. INGESTION BY DOGS AND HORSES
MAY BE FATAL.
PRECAUTIONS
RECOMMENDED LEVELS OF PHIBROMONENSIN MUST NOT BE EXCEEDED. HIGH LEVELS
CAN CAUSE REDUCED FEED INTAKE, POOR GROWTH, DISEASE
AND DEATH.
RESPONSES TO PHIBROMONENSIN ARE UNLIKELY IF THE NUTRIENT INTAKE IS
SIGNIFICANTLY RESTRICTED.
RESPONSES TO PHIBROMONENSIN IN PASTURE CATTLE MAY NOT OCCUR IF PASTURE
QUALITY IS POOR OR IF WEATHER CONDITIONS ARE VERY HOT AND
DRY.
POULTRY CONSUMING MONENSIN SODIUM SHOULD NOT BE TREATED WITH TIAMULIN.
SEVERE GROWTH DEPRESSION OR DEATH MAY OCCUR.
As per Good Industry Practice, colostrum and milk collected within 96
hours (8 milkings) after calving should not be used for human
consumption or processing. Feeding monensin to lactating dairy cows
may result in decreased milk fat percentage, but there is no
effect on total fat yield.
MIXING DIRECTIONS
PhibroMonensin m

Read the complete document

Summary of Product characteristics

PRODUCT NAME: PHIBROMONENSIN 100 MONENSIN FEED
ADDITIVE PREMIX
PAGE: 1 OF 5
THIS REVISION ISSUED: APRIL, 2008

MATERIAL SAFETY DATA SHEET
Issued by: Phibro Animal Health Pty Ltd
Phone: (02) 9896 4666
POISONS INFORMATION CENTRE: 13 1126 FROM ANYWHERE IN AUSTRALIA, (0800
764 766 IN NEW ZEALAND)

SECTION 1 - IDENTIFICATION OF CHEMICAL PRODUCT AND COMPANY
PHIBRO ANIMAL HEALTH PTY LTD
PHONE:
02 9896 4666
UNIT 4, 129 MAGOWAR RD
FAX
02 9896 4544
GIRRAWEEN, NSW 2145
AFTER HOURS: 0418 213 734
SUBSTANCE:
Natural polyether ionophore antibiotic from _Streptomyces
cinnamonensis_.

TRADE NAME:
PHIBROMONENSIN 100 MONENSIN FEED ADDITIVE PREMIX

PRODUCT USE:
Feed additive premix for cattle and poultry for use as described on
the product label.

CREATION DATE:
APRIL, 2008
REVISION DATE:
APRIL, 2008
SECTION 2 - HAZARDS IDENTIFICATION
STATEMENT OF HAZARDOUS NATURE
This product is classified as: Xn, Harmful. Hazardous according to
the criteria of ASCC.
Not a Dangerous Good according to the Australian Dangerous Goods
(ADG) Code.

RISK PHRASES: R21/22. Harmful in contact with skin and if swallowed.

SAFETY PHRASES: S20, S45, S24/25. When using, do not eat or drink.
In case of accident or if you feel unwell,
contact a doctor or Poisons Information Centre immediately (show this
MSDS where possible). Avoid contact with
skin and eyes.
SUSDP CLASSIFICATION: S6
ADG CLASSIFICATION: None allocated. Not a Dangerous Good under the
ADG Code.
UN NUMBER: None allocated
EMERGENCY OVERVIEW
PHYSICAL DESCRIPTION & COLOUR: Dark brown, free flowing granular meal
speckled with straw coloured particles.
ODOUR: May smell of amyl alcohol.
MAJOR HEALTH HAZARDS: harmful in contact with skin, and if
swallowed. A significant ingredient is an antibiotic. Any
person with a history of allergies to this class of
substances should avoid all contact with this product as it may
cause
sensitisation.
POTENTIAL HEALTH EFFECTS
i) Eff

Read the complete document